Cases 11 - 20 of 59
Allergan, Inc. v. Aurobindo Pharma Limited et al
as 1:2021cv01808
Plaintiff:
Allergan, Inc.
Defendant:
Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Limited
Cause Of Action: 35 U.S.C. § 271
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Taro Pharmaceutical Industries Ltd. et al v. Encube Ethicals Pvt. Ltd.
as 1:2021cv01614
Counter Defendant:
Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals North America, Inc. and Taro Pharmaceuticals U.S.A., Inc.
Defendant:
Encube Ethicals Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 1
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2021cv01000
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271
Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al
as 1:2021cv00003
Plaintiff:
AMAG Pharmaceuticals, Inc., AMAG Pharma USA, Inc. and Covis Pharma GmbH
Defendant:
Aurobindo Pharma, Ltd., Aurobindo Pharma U.S.A., Inc. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 1
Takeda Pharmaceutical Company Limited et al v. Norwich Pharmaceuticals, Inc. et al
as 1:2020cv00953
Defendant:
Alvogen Group, Inc., Alvogen PB Research And Development LLC, Norwich Pharmaceuticals, Inc. and others
Plaintiff:
Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271
Chiesi USA, Inc. et al v. Hikma Pharmaceuticals USA, Inc.
as 1:2020cv00484
Defendant:
EuroHealth (U.S.A.) Inc., Hikma Pharmaceuticals PLC and Hikma Pharmaceuticals USA, Inc.
Plaintiff:
Chiesi USA, Inc. and Chiesi Farmaceutici S.p.A.
Cause Of Action: 35 U.S.C. § 271
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al
as 1:2019cv02309
Plaintiff:
Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd.
Defendant:
Aurobindo Pharma U.S.A., Inc., Eugia Pharma Specialities Ltd. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Teijin Limited et al v. Alkem Laboratories Limited et al
as 1:2019cv00768
Plaintiff:
Teijin Pharma Limited, Teijin Limited and Takeda Pharmaceuticals U.S.A., Inc.
Defendant:
Ascend Laboratories, LLC and Alkem Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
